Stock Track | Oscar Health Soars 5.00% Intraday as Company Reaffirms Guidance and UBS Raises Target Price

Stock Track

05/13

Oscar Health, Inc. (OSCR) saw its stock price soar by 5.00% during intraday trading on Tuesday, significantly outperforming the broader market and its sector peers.

The surge was driven by multiple positive catalysts. The company recently reaffirmed its current financial guidance, confirming its development trajectory remains on track. Additionally, Oscar Health signaled plans to significantly expand its profit margins and committed to achieving key profitability milestones, boosting investor confidence in its future earnings potential.

Furthermore, the rally was fueled by an analyst action, as UBS raised its target price on Oscar Health from $15 to $20 while maintaining a Neutral rating. This upgrade, combined with the company's positive operational outlook, propelled the stock well past the average analyst target price.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1151767868"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1151767868\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1151767868?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-13 01:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1151767868","market":"nz","top_or_hot":-1,"title":"Stock Track | Oscar Health Soars 5.00% Intraday as Company Reaffirms Guidance and UBS Raises Target Price","media":"Stock Track","content":"<p>Oscar Health, Inc. (OSCR) saw its stock price soar by 5.00% during intraday trading on Tuesday, significantly outperforming the broader market and its sector peers.</p><p>The surge was driven by multiple positive catalysts. The company recently reaffirmed its current financial guidance, confirming its development trajectory remains on track. Additionally, Oscar Health signaled plans to significantly expand its profit margins and committed to achieving key profitability milestones, boosting investor confidence in its future earnings potential.</p><p>Furthermore, the rally was fueled by an analyst action, as UBS raised its target price on Oscar Health from $15 to $20 while maintaining a Neutral rating. This upgrade, combined with the company's positive operational outlook, propelled the stock well past the average analyst target price.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Oscar Health Soars 5.00% Intraday as Company Reaffirms Guidance and UBS Raises Target Price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Oscar Health Soars 5.00% Intraday as Company Reaffirms Guidance and UBS Raises Target Price\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-05-13 01:55</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Oscar Health, Inc. (OSCR) saw its stock price soar by 5.00% during intraday trading on Tuesday, significantly outperforming the broader market and its sector peers.</p><p>The surge was driven by multiple positive catalysts. The company recently reaffirmed its current financial guidance, confirming its development trajectory remains on track. Additionally, Oscar Health signaled plans to significantly expand its profit margins and committed to achieving key profitability milestones, boosting investor confidence in its future earnings potential.</p><p>Furthermore, the rally was fueled by an analyst action, as UBS raised its target price on Oscar Health from $15 to $20 while maintaining a Neutral rating. This upgrade, combined with the company's positive operational outlook, propelled the stock well past the average analyst target price.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OSCR","symbol_name":"Oscar Health, Inc.","start_time":0,"source_url":"","article_id":"1151767868","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1151767868","pubTimestamp":1778608535,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Oscar Health, Inc. (OSCR) saw its stock price soar by 5.00% during intraday trading on Tuesday, significantly outperforming the broader market and its sector peers.The surge was driven by multiple...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OSCR":"Oscar Health, Inc."},"translate_title":"个股追踪|奥斯卡健康盘中大涨5.00%公司重申指引瑞银上调目标价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OSCR":1},"content_text":"Oscar Health, Inc. (OSCR) saw its stock price soar by 5.00% during intraday trading on Tuesday, significantly outperforming the broader market and its sector peers.The surge was driven by multiple positive catalysts. The company recently reaffirmed its current financial guidance, confirming its development trajectory remains on track. Additionally, Oscar Health signaled plans to significantly expand its profit margins and committed to achieving key profitability milestones, boosting investor confidence in its future earnings potential.Furthermore, the rally was fueled by an analyst action, as UBS raised its target price on Oscar Health from $15 to $20 while maintaining a Neutral rating. This upgrade, combined with the company's positive operational outlook, propelled the stock well past the average analyst target price.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}